Aben Chemicals and Hengrui Medicine have inked a strategic supply agreement, with the aim of advancing technological innovation and elevating the quality of pharmaceutical intermediates and active pharmaceutical ingredients. This partnership aims to bolster the collaborative strength of the pharmaceutical industry chain and foster mutual benefits. While this agreement sets the stage for future project collaborations, the specific transaction amount remains undisclosed, and the details of its implementation are yet to be determined.